This HTML5 document contains 67 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
n7http://dx.doi.org/10.1002/
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q82837990
rdf:type
wikibase:Item
schema:description
wetenschappelijk artikel scientific article published on 06 December 2011 artículu científicu espublizáu n'avientu de 2011 article scientifique publié en 2011 im Dezember 2011 veröffentlichter wissenschaftlicher Artikel наукова стаття, опублікована в грудні 2011
p:P577
wds:Q82837990-BB2DEEED-9C58-4171-A2B7-181D6062E056
wdt:P577
2011-12-06T00:00:00Z
p:P2093
wds:Q82837990-2507BE16-24F5-4FD6-BBC0-96FDAD6BEF80 wds:Q82837990-FAA6662F-0F0C-4C26-BC4C-A6B8EE0FF5F7 wds:Q82837990-DF302205-5312-436B-AFFF-457030F78D5C wds:Q82837990-96F43EF5-A868-4C06-9A47-5818E8B3369D wds:Q82837990-D66AECE8-8166-4261-AD84-DA3727AC4480 wds:Q82837990-57AD0D16-0D70-4040-9E63-377941AB15DE wds:Q82837990-5D7D833B-E4F1-4D94-883B-C69EA76A308F wds:Q82837990-6A8202DF-0FA2-4E53-9C2D-EC2AE31A1446 wds:Q82837990-819FCB72-6B27-4C50-B1C4-9AF981C39505 wds:Q82837990-043F90FF-04C2-4679-AA46-4E85FAB1A896 wds:Q82837990-3DF9380D-F83F-4A4C-BB41-D24A97D8282A
wdt:P2093
Andra Balanescu Michael Yellin Rodica Chirieac Xiaolu Tao Semen Ter-Vartanian Vira Tseluyko Li-An Xu Heidi Leblanc Geoff Nichol Allison Luo Pina M Cardarelli
rdfs:label
A phase II, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of MDX-1100, a fully human anti-CXCL10 monoclonal antibody, in combination with methotrexate in patients with rheumatoid arthritis A phase II, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of MDX-1100, a fully human anti-CXCL10 monoclonal antibody, in combination with methotrexate in patients with rheumatoid arthritis
skos:prefLabel
A phase II, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of MDX-1100, a fully human anti-CXCL10 monoclonal antibody, in combination with methotrexate in patients with rheumatoid arthritis A phase II, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of MDX-1100, a fully human anti-CXCL10 monoclonal antibody, in combination with methotrexate in patients with rheumatoid arthritis
schema:name
A phase II, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of MDX-1100, a fully human anti-CXCL10 monoclonal antibody, in combination with methotrexate in patients with rheumatoid arthritis A phase II, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of MDX-1100, a fully human anti-CXCL10 monoclonal antibody, in combination with methotrexate in patients with rheumatoid arthritis
p:P50
wds:Q82837990-4A8A579B-8DFD-452E-B52C-76DC285D10EC wds:Q82837990-B056E00C-258B-42DB-A96F-98456EEBC582
wdt:P50
wd:Q82837985 wd:Q82340317
p:P1476
wds:Q82837990-923C28E4-49C2-431A-9D7D-72663B059577
wdt:P1476
A phase II, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of MDX-1100, a fully human anti-CXCL10 monoclonal antibody, in combination with methotrexate in patients with rheumatoid arthritis
p:P304
wds:Q82837990-D45588E9-6B9A-44D1-9D09-3DA1D73FC7B7
wdt:P304
1730-1739
p:P31
wds:Q82837990-8D296EF5-0ED6-46CD-B989-5A1310264996
wdt:P31
wd:Q13442814
p:P921
wds:Q82837990-D819CE1A-AACC-4DA4-8F24-F2C3A083EA5F wds:Q82837990-DFB17316-60A6-473C-9882-CE2DB2575F57 wds:Q82837990-3026C7B0-413E-4DAD-9F29-983F4E98A725 wds:Q82837990-55D87C67-D368-4C9F-BDDC-7749AD879D99
wdt:P921
wd:Q187255 wd:Q422232 wd:Q269829 wd:Q422248
p:P698
wds:Q82837990-9778664D-F9F3-4523-959B-6F6FC37A650A
wdtn:P698
n10:22147649
wdt:P698
22147649
p:P1433
wds:Q82837990-A070A008-B0A1-425F-8214-5DFB81606882
wdt:P1433
wd:Q23929027
p:P433
wds:Q82837990-3EA5A778-ECBD-4B77-928F-0D2D78C061D6
p:P478
wds:Q82837990-1A71163F-9365-4FBC-B53F-787D8CC99843
wdt:P433
6
wdt:P478
64
p:P356
wds:Q82837990-D928BCD3-FE0D-4369-9429-5459C0B486EE
wdtn:P356
n7:ART.34330
wdt:P356
10.1002/ART.34330